SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short duration. We propose here that coronaviruses employ a structural strategy to avoid strong and enduring antibody responses. Other viruses induce optimal and long-lived neutralizing antibody responses, thanks to 20...
Guardado en:
Autores principales: | Martin F. Bachmann, Mona O. Mohsen, Lisha Zha, Monique Vogel, Daniel E. Speiser |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7313fd10fc4641f6969e99ac1f05398f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain
por: Xinyue Chang, et al.
Publicado: (2021) -
Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
por: Chaojie Zhong, et al.
Publicado: (2021) -
Neutralizing antibody titres in SARS-CoV-2 infections
por: Eric H. Y. Lau, et al.
Publicado: (2021) -
Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
por: Mona O. Mohsen, et al.
Publicado: (2021) -
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
por: Edurne Rujas, et al.
Publicado: (2021)